Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Tenax Therapeutics stock
Learn how to easily invest in Tenax Therapeutics stock.
Tenax Therapeutics Inc is a biotechnology business based in the US. Tenax Therapeutics shares (TENX) are listed on the NASDAQ and all prices are listed in US Dollars. Tenax Therapeutics employs 8 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Tenax Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – TENX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Tenax Therapeutics stock price (NASDAQ: TENX)Use our graph to track the performance of TENX stocks over time.
Tenax Therapeutics shares at a glance
|Latest market close||$0.32|
|52-week range||$0.23 - $2.27|
|50-day moving average||$0.63|
|200-day moving average||$0.97|
|Wall St. target price||$4.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.49|
Buy Tenax Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Tenax Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Tenax Therapeutics price performance over time
|1 week (2022-06-24)||2.51%|
|1 month (2022-06-01)||-51.79%|
|3 months (2022-04-01)||-59.11%|
|6 months (2021-12-31)||-69.40%|
|1 year (2021-07-02)||-83.85%|
|2 years (2020-07-02)||-64.75%|
|3 years (2019-07-02)||1.35|
|5 years (2017-06-30)||0.7391|
Tenax Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-158.13%|
|Return on equity TTM||-486.94%|
|Market capitalisation||$7.8 million|
TTM: trailing 12 months
Tenax Therapeutics share dividends
We're not expecting Tenax Therapeutics to pay a dividend over the next 12 months.
Have Tenax Therapeutics's shares ever split?
Tenax Therapeutics's shares were split on a 1:20 basis on 25 February 2018. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Tenax Therapeutics shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Tenax Therapeutics shares which in turn could have impacted Tenax Therapeutics's share price.
Tenax Therapeutics share price volatility
Over the last 12 months, Tenax Therapeutics's shares have ranged in value from as little as $0.234 up to $2.266. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tenax Therapeutics's is 2.0113. This would suggest that Tenax Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Tenax Therapeutics overview
Tenax Therapeutics, Inc. , a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc.
Tenax Therapeutics in the news
Chapel Hill company given extension to regain Nasdaq compliance
Frequently asked questionsWhat percentage of Tenax Therapeutics is owned by insiders or institutions?
Currently 36.222% of Tenax Therapeutics shares are held by insiders and 32.073% by institutions. How many people work for Tenax Therapeutics?
Latest data suggests 8 work at Tenax Therapeutics. When does the fiscal year end for Tenax Therapeutics?
Tenax Therapeutics's fiscal year ends in December. Where is Tenax Therapeutics based?
Tenax Therapeutics's address is: ONE Copley Parkway, Morrisville, NC, United States, 27560 What is Tenax Therapeutics's ISIN number?
Tenax Therapeutics's international securities identification number is: US88032L2097 What is Tenax Therapeutics's CUSIP number?
Tenax Therapeutics's Committee on Uniform Securities Identification Procedures number is: 69207P100
More guides on Finder
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert